Core Insights - Altria is expected to announce earnings on July 30, 2025, with analysts projecting earnings of $1.38 per share and revenues of $5.19 billion, compared to $1.31 per share and $5.28 billion in the same quarter last year [3][4]. Group 1: Historical Performance - Over the past five years, Altria's stock has shown a positive one-day return in 53% of cases following earnings announcements, with a median one-day increase of 1.9% and a maximum increase of 7.8% [3][7]. - In the last three years, the percentage of positive one-day returns increased to 55%, with the median of positive returns at 1.9% and negative returns at -2.1% [7]. Group 2: Financial Metrics - Altria has a current market capitalization of $101 billion, generating $20 billion in revenue over the past twelve months, with $12 billion in operating profits and a net income of $10 billion, indicating strong operational profitability [4]. Group 3: Trading Strategies - Traders may consider pre-earnings positioning based on historical probabilities and evaluate immediate and mid-term stock reactions post-earnings to inform trading decisions [6]. - Correlation between short-term and medium-term returns can be analyzed to identify suitable trading strategies, particularly if the 1D and 5D returns show high correlation [8].

Core Viewpoint - Altria Group, Inc. is expected to report a decline in revenues for Q2 2025, while earnings are projected to show growth compared to the previous year [1][9]. Revenue and Earnings Estimates - The Zacks Consensus Estimate for Q2 revenues is $5.2 billion, reflecting a 1.7% decrease from the same period last year [1]. - The consensus estimate for earnings per share (EPS) has increased to $1.37, indicating a 4.6% growth year-over-year [1][9]. Earnings Performance and Predictions - Altria has a trailing four-quarter average earnings surprise of 1.3%, with the last quarter's earnings exceeding the Zacks Consensus Estimate by 5.1% [2]. - The company currently has an Earnings ESP of +1.03% and a Zacks Rank of 3 (Hold), suggesting a potential earnings beat [4][3]. Factors Influencing Q2 Earnings - Regulatory pressures, particularly the ITC's exclusion order on NJOY ACE, have negatively impacted Altria's smoke-free product portfolio [5]. - The cigarette business is facing volume pressures due to consumer downtrading and competition from illicit flavored disposable vapes [5]. - Despite these challenges, Altria's strong pricing power and cost control measures are expected to support profitability [6][7]. Stock Performance - Over the past three months, Altria's stock has increased by 2.6%, slightly below the Zacks Tobacco industry's growth of 2.7% and significantly trailing the S&P 500's 15.5% rise [8]. - Altria's stock performance has outpaced Philip Morris International, which declined by 6.8%, but underperformed Turning Point Brands and British American Tobacco [8]. Valuation Analysis - Altria shares are trading at a forward 12-month price-to-earnings (P/E) ratio of 10.96, below the industry average of 14.48, indicating attractive value for investors [11]. - Compared to key competitors, Altria's P/E ratio is significantly lower than Philip Morris International (20.11) and Turning Point Brands (21.54), while being comparable to British American Tobacco (10.94) [13]. Investment Outlook - Altria faces a mixed backdrop with regulatory challenges and volume pressures, but resilient pricing power and disciplined cost control may provide stability [14]. - Investors may consider holding positions or selectively adding to their investments, while monitoring management's updates on product pipeline and strategic execution [14].

Core Insights - The tobacco sector presents two main investment options: Altria Group, Inc. and Philip Morris International Inc., each with distinct market strategies and growth trajectories towards a smoke-free future [1][2] Altria Group, Inc. - Altria focuses on the U.S. market, leveraging its Marlboro brand while expanding into alternatives like NJOY and oral nicotine pouches [2] - The company achieved a 10.8% net price realization in smokeable products in Q1 2025, contributing to a 2.7% increase in adjusted operating income [3][9] - Altria's oral nicotine pouch brand, on!, saw an 18% increase in shipments, capturing 8.8% of the oral tobacco category and 17.9% of the nicotine pouch segment [4][9] - Despite setbacks in the e-vapor category, Altria is refining its product pipeline and advocating for regulatory reforms to combat the rise of illicit disposable e-vapor products, which account for over 60% of the U.S. market [5] - The cigarette industry faces challenges, with shipment volumes declining due to macroeconomic pressures and the growth of illegal e-vapor products, impacting low-income smokers [6] Philip Morris International Inc. - Philip Morris is advancing its transformation strategy with a strong smoke-free portfolio, including IQOS, ZYN, and VEEV, and has approximately 41.5 million adult users by Q2 2025 [7][9] - IQOS is the primary driver of growth, with accelerated adoption in key markets supported by commercial initiatives and product innovations [8][10] - The company offers smoke-free products in 97 markets, with nearly half providing multiple product categories, enhancing its global reach [10] - Philip Morris faces challenges such as currency volatility and increasing regulatory risks, particularly regarding nicotine pouch marketing [11] Financial Performance and Valuation - Altria's forward P/E ratio is 10.96, appealing to income-focused investors, while Philip Morris has a higher multiple of 20.12, reflecting its global presence and momentum in smoke-free products [15] - Over the past month, Altria gained 2.1%, while Philip Morris dropped 11.6%, underperforming the S&P 500's 3.4% rise [14] Conclusion - Philip Morris is better positioned for long-term growth with its aggressive pivot towards a smoke-free future and strong global traction, while Altria's focus on domestic stability and pricing strength supports income-focused investors but faces more headwinds [16]

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. Wha ...

Core Insights - The article discusses the investment landscape, focusing on long-term wealth creation through companies with strong profitability and attractive valuations [1][2] Altria Group - Altria Group is highlighted as a potentially undervalued stock despite a 20% rally over the past 12 months, with a current price of $59.59 and a 12-month forecast of $56.75, indicating a downside of 4.76% [4] - The company offers a dividend payout of $4.08 per share, resulting in an annualized yield of 6.9%, which is higher than U.S. inflation rates and Treasury bond yields [5] - Altria generates a return on invested capital (ROIC) of 42.8%, which supports its stock price performance and potential for capital compounding [6] - There has been an 8.1% decline in short interest over the past month, suggesting bearish capitulation among short sellers [7] Mastercard - Mastercard is presented as a strong investment opportunity with a current price of $568.18 and a 12-month price forecast of $612.90, indicating a potential upside of 7.87% [10] - The company boasts a ROIC of 56.6%, contributing to its stability and resilience during market volatility [11] - Analyst Timothy Chiodo from UBS Group has reiterated a Buy rating for Mastercard, setting a valuation target of $670 per share, implying a potential rally of 21% [12] Ulta Beauty - Ulta Beauty is characterized as a resilient business within the consumer discretionary sector, with a current price of $514.95 and a 12-month forecast of $465.04, indicating a downside of 9.69% [14] - The company achieves a ROIC of 26.8% and has seen a 32% rally over the past quarter, leading to a significant reduction in short interest [15] - Analyst Michael Baker from DA Davidson has expressed a bullish outlook for Ulta, with a Buy rating and a valuation target of $550 per share, suggesting an additional return of up to 11% [16]

Core Viewpoint - Analysts forecast Altria (MO) to report quarterly earnings of $1.37 per share, reflecting a year-over-year increase of 4.6%, while revenues are expected to be $5.19 billion, a decrease of 1.6% compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has been adjusted downward by 0.5% over the past 30 days, indicating a reassessment by covering analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3] Revenue Projections - Analysts estimate 'Net revenue- All Other/ Financial Services' to reach $14.00 million, a significant increase of 366.7% from the prior-year quarter [5] - 'Revenues net of excise taxes- Oral tobacco products' are projected at $701.72 million, showing a 2.1% increase year-over-year [5] - 'Revenues net of excise taxes- Smokeable Products' are expected to be $4.43 billion, indicating a decline of 3.3% compared to the previous year [6] Operating Income Estimates - The average prediction for 'Operating Income (Loss)/ Reported OCI- Oral tobacco products' is $459.60 million, compared to $97.00 million reported in the same quarter last year [6] - 'Adjusted OCI- Smokeable Products' is anticipated to reach $2.86 billion, slightly up from $2.83 billion reported in the same quarter of the previous year [7] Market Performance - Altria shares have returned +1.4% over the past month, underperforming compared to the Zacks S&P 500 composite's +4.6% change [7] - Altria holds a Zacks Rank 3 (Hold), suggesting it is expected to mirror overall market performance in the near future [7]

Group 1 - The focus is on growth and dividend income as a strategy for retirement planning [1] - The portfolio is structured to generate monthly dividend income that grows through reinvestment and annual increases [1] Group 2 - The article expresses personal opinions and is not intended as investment advice [2] - It emphasizes the importance of conducting individual research before making investment decisions [2]

Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.My last analysis on Altria Group, Inc. (NYSE: MO ) stock was published on June 5 in an article titled "Altria: Wall Street Missed Half Of The Equation.” The focus of theSensor Unlimited contributes to the investing group Envision Early Retirement which is led by Sensor Unlimited. They offer proven solutions to generate both high income and high growth with isola ...

Core Viewpoint - Altria is expected to report a year-over-year increase in earnings despite a decline in revenues for the quarter ended June 2025, with the consensus outlook indicating potential impacts on its stock price based on actual results compared to estimates [1][3]. Earnings Expectations - The consensus estimate for Altria's quarterly earnings is $1.37 per share, reflecting a year-over-year increase of +4.6%, while revenues are projected to be $5.19 billion, down 1.7% from the previous year [3]. - A positive earnings surprise could lead to a stock price increase, while a miss could result in a decline [2]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 0.51%, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Altria is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.03%, suggesting a bullish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Altria currently holds a Zacks Rank of 3, which, combined with the positive Earnings ESP, suggests a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Altria exceeded the expected earnings of $1.17 per share by delivering $1.23, resulting in a surprise of +5.13% [13]. - Over the past four quarters, Altria has beaten consensus EPS estimates three times [14]. Conclusion - Altria is positioned as a compelling candidate for an earnings beat, but investors should consider other factors influencing stock performance beyond just earnings results [17].

Core Insights - Altria Group's on! nicotine pouch brand is experiencing significant growth, with shipments increasing by 18% to 39.3 million cans in Q1 2025, contrasting with declines in traditional brands [1][8] - The on! brand now holds an 8.8% share of the total oral tobacco market and a 17.9% share of the nicotine pouch segment, despite rising competition [2][8] - Helix, the manufacturer of on!, has successfully increased brand awareness to over 60% through its "It's On!" campaign, enhancing consumer loyalty [3][8] Market Performance - Philip Morris International's ZYN brand leads the nicotine pouch category, shipping over 200 million cans in Q1 2025, a 63% increase year over year, maintaining over 70% of category value [5] - Turning Point Brands reported a nearly tenfold increase in modern oral revenues to $22.3 million in Q1 2025, raising its full-year nicotine pouch sales forecast to $80-$95 million [6] Valuation and Earnings Estimates - Altria's shares have declined by 2.6% in the past month, while the industry saw a smaller decline of 0.8% [7] - The forward price-to-earnings ratio for Altria is 10.8X, lower than the industry's average of 15.21X [10] - Zacks Consensus Estimates indicate year-over-year earnings growth of 4.9% for 2025 and 3.1% for 2026 [11]